Side Effects of nadolol: A Synthesis of Findings from 26 Studies
- Home
- Side Effects of nadolol
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of nadolol: A Synthesis of Findings from 26 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major research findings
Nadolol is a beta-blocker that has been shown to be effective in treating a variety of conditions, including chronic simple glaucoma ( 26 ), hypertension ( 2 ), migraine ( 8 ), and esophageal variceal bleeding ( 16 ). However, there are some reported side effects associated with its use.
Reasons for side effects
Nadolol's side effects are due to its action as a beta-blocker, affecting various tissues like the heart, blood vessels, and airways. This can lead to side effects such as a slower heart rate, constricted blood vessels, and narrowed airways.
Common side effects
Acne-like dermatitis
Nadolol has been reported to cause acne-like dermatitis in patients with migraine ( 8 ).
Mild side effects
Nadolol has been associated with mild side effects in patients with chronic simple glaucoma, including fatigue and other symptoms related to its beta-blocking action ( 26 ).
Bradycardia
Nadolol, a beta-adrenergic antagonist, can cause bradycardia, hypotension, hypoglycemia, and even death due to its toxicity ( 23 ).
Hypotension
Nadolol, a beta-adrenergic antagonist, can cause bradycardia, hypotension, hypoglycemia, and even death due to its toxicity ( 23 ).
Hypoglycemia
Nadolol, a beta-adrenergic antagonist, can cause bradycardia, hypotension, hypoglycemia, and even death due to its toxicity ( 23 ).
Death
Nadolol has been associated with death in infants with infantile hemangioma ( 23 ).
Measures to counter side effects
Acne-like dermatitis
If you experience acne-like dermatitis while taking nadolol, consult your doctor. They may advise you to stop taking nadolol or switch to a different medication.
Mild side effects
If you experience mild side effects while taking nadolol, talk to your doctor about them. They may adjust your dose or recommend alternative therapies.
Bradycardia, Hypotension, Hypoglycemia, Death
If you experience any of these severe side effects, seek immediate medical attention. It is crucial to monitor your heart rate, blood pressure, and blood sugar levels while taking nadolol, especially in vulnerable patient populations such as infants.
Comparison across studies
Commonalities in research
Nadolol has been shown to be effective in treating various conditions and is generally well-tolerated. However, the studies indicate that nadolol, like other beta-blockers, can have a range of side effects. These side effects are often mild and may be manageable with dose adjustments or alternative therapies.
Differences in research
The incidence and severity of side effects vary across studies and depend on individual patient factors. For instance, severe side effects, like death, have only been reported in infants with infantile hemangioma ( 23 ). More research is needed to clarify the factors contributing to these variations and identify specific populations at higher risk for particular side effects.
Points to note in applying to real life
Nadolol is a beneficial medication for various health conditions, but it's important to be aware of its potential side effects. Consult your doctor before starting nadolol, discuss your medical history, and adhere to their recommendations for dosage and administration. It is essential to report any unusual symptoms or changes in your health to your doctor while taking nadolol.
Limitations of current research
Research on nadolol is still limited, particularly on its long-term effects and efficacy in specific conditions. There is a need for further research to better understand the factors influencing side effects and to develop strategies to mitigate them.
Future research directions needed
Future research should focus on the long-term effects of nadolol, its efficacy in specific populations and conditions, and the development of safer alternatives to minimize the risk of severe side effects. More research is also needed to clarify the factors contributing to the variations in side effect frequency and severity across different studies.
Conclusion
Nadolol is a valuable medication for various conditions, but it's essential to be aware of its potential side effects and discuss any concerns with your doctor. It is crucial to be vigilant, monitor your health closely, and follow your doctor's recommendations to ensure the safe and effective use of this medication. Further research is necessary to address the current limitations and enhance our understanding of nadolol's safety profile.
Benefit Keywords
Risk Keywords
Article Type
Author: HitzenbergerG
Language : English
Author: HaydukK
Language : English
Author: PupitaF, AnsuiniR, BelogiM, CampolucciG, GaggiS, PupitaG
Language : English
Author: BorroniGianmario, SalernoFrancesco, CazzanigaMassimo, BissoliFranco, LorenzanoElettra, MaggiAlessandra, VisentinStefania, PanzeriAnna, de FranchisRoberto
Language : English
Author: SvishchenkoE P, KupchinskaiaE G, ZanozdraN S, BezrodnaiaL V, RadchenkoV V
Language : Russian
A comparison of the efficacy of sotalol and nadolol in the suppression of ventricular ectopic beats.
Author: MyburghD P, SmithR, DiamondT H, FaitelsonH L, SommersD K
Language : English
Language : English
Author: OsterlohI
Language : English
Author: HermanV S, JoffeB I, KalkW J, PanzV, WingJ, SeftelH C
Language : English
Author: WilliamsonJ, AttaH R, KennedyP A, MuirJ G
Language : English
Author: El-MehairyM M, ShakerA, RamadanM, HamzaS, TadrosS S
Language : English
Author: RomakovA Iu, SagirovA M, DesiatnichenkoV M, Sobol'Iu S, SumarokovA B
Language : Russian
Author: GattaA, BolognesiM, MerkelC, FinucciG F, AngeliP, SacerdotiD, RuolA
Language : English
Author: TandonPuneeta, SaezRosa, BerzigottiAnnalisa, AbraldesJuan G, Garcia-PaganJuan Carlos, BoschJaime
Language : English
Author: VillanuevaC, MiñanaJ, OrtizJ, GallegoA, SorianoG, TorrasX, SáinzS, BoadasJ, CussóX, GuarnerC, BalanzóJ
Language : English
Author: PrinssenE P, EllenbroekB A, CoolsA R
Language : English
Author: MetelitsaV I, FilatovaN P
Language : Russian
Efficacy and safety of intravenous and oral nadolol for supraventricular tachycardia in children.
Author: MehtaA V, ChidambaramB
Language : English
Author: GonzalezD, ElizondoB J, HaslagS, BuchananG, BurdickJ S, GuzzettaP C, HicksB A, AndersenJ M
Language : English
Author: LemmerB
Language : German
Author: OlesenJ
Language : English
Author: McGillisEric, BaumannTravis, LeRoyJenna
Language : English
Author: ConnorD F, OzbayrakK R, BenjaminS, MaY, FletcherK E
Language : English
Author: Gracia-NayaManuel, Santos-LasaosaSonia, Ríos-GómezConsuelo, Sánchez-ValienteSara, García-GomaraM José, Latorre-JiménezAna M, Artal-RoyJorge, Mauri-LlerdaJosé A
Language : Spanish
Author: DowdT C, HardingS, RennieI
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.